Jpmorgan Chase & Co »

Iovance Biotherapeutics Inc call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Iovance Biotherapeutics Inc call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Iovance Biotherapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics Inc call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics Inc call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $208k 14k 14.82
2020-06-30 $20M 710k 27.45
2020-03-31 $25M 843k 29.93
2019-12-31 $14M 516k 27.68
2019-09-30 $1.4M 75k 18.20

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Iovance Biotherapeutics Inc call

Group One Trading
Jane Street
Simplex Trading
Jpmorgan Chase & Co

View all funds holding Iovance Biotherapeutics Inc call